At Biomedix, we strive to promote top-notch vascular care and have compiled the reimbursement rates for PADnet tests, including CPT codes 93922, 93923, and 93924, as well as office visit E/M codes, for the year 2023. Market-by-market data has been gathered and the published Medicare reimbursement rates are available. This Read more…
FDA Clearance For PADnet Xpress For Home Use Twin Cities, MN— November 30th, 2022 — Biomedix, a market-leading medical technology and innovation company, announced that the PADnet Xpress device has received clearance from the FDA for use in the home. “We are excited to announce the expanded clearance for in-home use of Read more…
New integration option aggregating bi-directional interfacing between multiple devices across multiple modalities. Twin Cities, MN — October 6th, 2022 Biomedix announced the availability of a bi-directional interface designed to support the automated integration between their Biomedix Xchange point-of-care diagnostic platform, with customer and stakeholder EMRs, CRMs, and other systems of Read more…
At the latest International Symposium on Endovascular Therapy (ISET) show, PADnet Xpress was featured in a medical poster that MIMIT Healthcare submitted, highlighting the clinical value of a population health screening for PAD in a Specialized Nursing Facility (SNF), and the combined clinical accuracy, speed, and ease-of-use of PADnet Xpress. Read more…
A recent study published in the Annals of Internal Medicine found that one sixth of patients admitted to a hospital for revascularization for Peripheral Artery Disease (PAD) were readmitted to the hospital within 30 days. Primary reasons were complications, sepsis, and diabetes. The study involved 1,085 US acute care hospitals, covering 61,969 Read more…
In a study published in the European Journal of Preventive Cardiology, results indicated that patients with heart disease were hospitalized less if they walked at a faster pace. This study was based on results of 1,078 hypertensive patients, of whom 85% also had coronary heart disease and 15% also had heart valve disease. At the Read more…